| 1 | [SID104233675] | Active | CC50 | 50 | Vero Cytoxicity Assay: A Cell Based Secondary Assay To Explore Cytotoxicity of Compounds that Inhibit Plasmodium falciparum M1 Aspartyl Aminopeptidase (PFM17LAP) [AID588707, Type: confirmatory] | |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 104233675 | | CID | 24237873 | | Outcome | Active | | CC50 | 50 [uM] | | BioAssay | Vero Cytoxicity Assay: A Cell Based Secondary Assay To Explore Cytotoxicity of Compounds that Inhibit Plasmodium falciparum M1 Aspartyl Aminopeptidase (PFM17LAP) | | AID | 588707 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 2 | [SID104233675] | Inactive | IC50 | | Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Human M17LAP (HUM17LAP) [AID602214, Type: confirmatory] | leucine aminopeptidase [Homo sapiens] [gi:4335941] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 104233675 | | CID | 24237873 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Human M17LAP (HUM17LAP) | | AID | 602214 | | BioAssay type | confirmatory | | Target | leucine aminopeptidase [Homo sapiens] [gi:4335941] | | PubMed | | | Data Table |  |
|
| 3 | [SID104233675] | Inactive | IC50 | | Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Human M17LAP (HUM17LAP) [AID602214, Type: confirmatory] | leucine aminopeptidase [Homo sapiens] [gi:4335941] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 104233675 | | CID | 24237873 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Human M17LAP (HUM17LAP) | | AID | 602214 | | BioAssay type | confirmatory | | Target | leucine aminopeptidase [Homo sapiens] [gi:4335941] | | PubMed | | | Data Table |  |
|
| 4 | [SID104233675] | Inactive | IC50 | | QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M17 Leucine Aminopeptidase (PFM17LAP) [AID588688, Type: confirmatory] | M17 leucyl aminopeptidase [Plasmodium falciparum 3D7] [gi:23497510] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 104233675 | | CID | 24237873 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M17 Leucine Aminopeptidase (PFM17LAP) | | AID | 588688 | | BioAssay type | confirmatory | | Target | M17 leucyl aminopeptidase [Plasmodium falciparum 3D7] [gi:23497510] | | PubMed | | | Data Table |  |
|
| 5 | [SID104233675] | Inactive | IC50 | | QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M17 Leucine Aminopeptidase (PFM17LAP) [AID588688, Type: confirmatory] | M17 leucyl aminopeptidase [Plasmodium falciparum 3D7] [gi:23497510] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 104233675 | | CID | 24237873 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M17 Leucine Aminopeptidase (PFM17LAP) | | AID | 588688 | | BioAssay type | confirmatory | | Target | M17 leucyl aminopeptidase [Plasmodium falciparum 3D7] [gi:23497510] | | PubMed | | | Data Table |  |
|
| 6 | [SID104233675] | Inactive | IC50 | | QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M17 Leucine Aminopeptidase (PFM17LAP) [AID588688, Type: confirmatory] | M17 leucyl aminopeptidase [Plasmodium falciparum 3D7] [gi:23497510] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 104233675 | | CID | 24237873 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M17 Leucine Aminopeptidase (PFM17LAP) | | AID | 588688 | | BioAssay type | confirmatory | | Target | M17 leucyl aminopeptidase [Plasmodium falciparum 3D7] [gi:23497510] | | PubMed | | | Data Table |  |
|
| 7 | [SID104233675] | Inactive | IC50 | | Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M18 Aspartyl Aminopeptidase (PFM18AAP) [AID588697, Type: confirmatory] | M18 aspartyl aminopeptidase [Plasmodium falciparum 3D7] [gi:23505220] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 104233675 | | CID | 24237873 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M18 Aspartyl Aminopeptidase (PFM18AAP) | | AID | 588697 | | BioAssay type | confirmatory | | Target | M18 aspartyl aminopeptidase [Plasmodium falciparum 3D7] [gi:23505220] | | PubMed | | | Data Table |  |
|
| 8 | [SID104233675] | Inactive | IC50 | | Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M18 Aspartyl Aminopeptidase (PFM18AAP) [AID588697, Type: confirmatory] | M18 aspartyl aminopeptidase [Plasmodium falciparum 3D7] [gi:23505220] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 104233675 | | CID | 24237873 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M18 Aspartyl Aminopeptidase (PFM18AAP) | | AID | 588697 | | BioAssay type | confirmatory | | Target | M18 aspartyl aminopeptidase [Plasmodium falciparum 3D7] [gi:23505220] | | PubMed | | | Data Table |  |
|
| 9 | [SID104233675] | Inactive | IC50 | | Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M1AAP (PFM1AAP) [AID588698, Type: confirmatory] | m1-family aminopeptidase [Plasmodium falciparum 3D7] [gi:23615263] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 104233675 | | CID | 24237873 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M1AAP (PFM1AAP) | | AID | 588698 | | BioAssay type | confirmatory | | Target | m1-family aminopeptidase [Plasmodium falciparum 3D7] [gi:23615263] | | PubMed | | | Data Table |  |
|
| 10 | [SID104233675] | Inactive | IC50 | | Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M1AAP (PFM1AAP) [AID588698, Type: confirmatory] | m1-family aminopeptidase [Plasmodium falciparum 3D7] [gi:23615263] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 104233675 | | CID | 24237873 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M1AAP (PFM1AAP) | | AID | 588698 | | BioAssay type | confirmatory | | Target | m1-family aminopeptidase [Plasmodium falciparum 3D7] [gi:23615263] | | PubMed | | | Data Table |  |
|